Defense / government contractors could be tech startups / additional companies
Crowdfunding / different funding sources could improve science and research
Pharmaceutical industry acquisitions could inhibit drug innovation and raise drug prices
Credit reports / background checks could be more accurate
NRSRO designation could be removed from SEC rules
